Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
Phase 1/2
55
about 5.5 years
18+
1 site in NY
Why this study is shown
What this study is about
Researchers are testing whether a treatment, non-invasive vagal nerve stimulation, or pyridostigmine can help with gastrointestinal problems and inflammation linked to vagus nerve dysfunction in people living with HIV. The trial will explore how the vagus nerve affects inflammation in the gut of people with HIV.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Placebos
- 2.Take Pyridostigmine
- 3.Undergo non-invasive vagal nerve stimulation
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
pyridostigmine
Primary: IL6 measurement [Time Frame: 5 years]
therapy
Immune, Infectious